Squarepoint
KMTS

Squarepoint’s Kestra Medical Technologies KMTS Stock Holding History

Squarepoint’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,098
Closed -$576K – 5215
2025
Q1 		$576K Buy
+23,098
New +$531K ﹤0.01% 3163

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Squarepoint's KMTS Position: Q2 2025 in Review

Squarepoint sold out of Kestra Medical Technologies (KMTS) in Q2 2025, closing a stake of 23,098 shares — an estimated $576K sold.

Squarepoint first reported a position in KMTS in Q1 2025 and held it in 1 quarter. The position peaked at $576K in Q1 2025. 73 funds tracked by Wall St. Rank hold KMTS as of Q2 2025.

  • Squarepoint reported no remaining Kestra Medical Technologies position as of Q2 2025 after selling out during the quarter.
  • Squarepoint sold 23,098 Kestra Medical Technologies shares in Q2 2025, an estimated $576K.
  • Squarepoint first reported a position in Kestra Medical Technologies in Q1 2025 and held it in 1 quarter.
  • Squarepoint's Kestra Medical Technologies position peaked at $576K in Q1 2025.
  • 73 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.